| Frontiers in Cellular Neuroscience | |
| Oligodendrocyte Development and Implication in Perinatal White Matter Injury | |
| Xianhua Piao1  Mahsa Motavaf3  | |
| [1] Division of Neonatology, Department of Pediatrics, University of California, San Francisco, San Francisco, CA, United States;Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, CA, United States;Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran;Newborn Brain Research Institute, University of California, San Francisco, San Francisco, CA, United States;Weill Institute for Neuroscience, University of California, San Francisco, San Francisco, CA, United States; | |
| 关键词: white matter injury; oligodendrocyte; premature birth; hypoxia-ischemia; myelin; | |
| DOI : 10.3389/fncel.2021.764486 | |
| 来源: DOAJ | |
【 摘 要 】
Perinatal white matter injury (WMI) is the most common brain injury in premature infants and can lead to life-long neurological deficits such as cerebral palsy. Preterm birth is typically accompanied by inflammation and hypoxic-ischemic events. Such perinatal insults negatively impact maturation of oligodendrocytes (OLs) and cause myelination failure. At present, no treatment options are clinically available to prevent or cure WMI. Given that arrested OL maturation plays a central role in the etiology of perinatal WMI, an increased interest has emerged regarding the functional restoration of these cells as potential therapeutic strategy. Cell transplantation and promoting endogenous oligodendrocyte function are two potential options to address this major unmet need. In this review, we highlight the underlying pathophysiology of WMI with a specific focus on OL biology and their implication for the development of new therapeutic targets.
【 授权许可】
Unknown